[Conclusive evaluation of osteoporosis therapy with fluorides].
Hesch
R D
RD
Abteilung Klinische Endokrinologie, Medizinische Hochschule Hannover.
Rittinghaus
E F
EF
D015519:Bone Density / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D005459:Fluorides / Q000009:adverse effects / Q000627:therapeutic use*; D005598:Fractures, Spontaneous / Q000517:prevention & control; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy* / Q000209:etiology; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000209:etiology; D012969:Sodium Fluoride / Q000009:adverse effects / Q000627:therapeutic use
D012969:Sodium Fluoride; D005459:Fluorides
Abschliessende Bewertung der Osteoporosetherapie mit Fluoriden.